According to the Daily Telegraph UDG Healthcare could make as many as four acquisitions in the US next year, its chief executive has said.
The Dublin-based company, which offers manufacturing, commercialisation and communication services to the pharmaceutical industry, is eyeing the US, which currently accounts for 52pc of annual profits. Next year, this will increase to 60pc, according to Brendan McAtamney, the company’s boss.